4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide
Discontinued Product
Unfortunately 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide (Cat. No. 0466) has been withdrawn from sale for commercial reasons.![Cat.No. 0466 - 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethylammonium iodide | CAS No. 141063-77-6](http://resources.tocris.com/images/datasheets/structures/4-n-4-chlorophenylcarbamoyloxy-4-pent-2-ynyl-trimethylammonium-iodide_0466.png "Cat.No. 0466 - 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethylammonium iodide | CAS No. 141063-77-6")
Biological Activity
A partial agonist with 16 times the power of the analogue McN-A-343 in increasing arterial blood pressure and 18 times the affinity of the latter for ganglionic M1 receptors.
Technical Data
| M. Wt | 422.69 |
| Storage | Store at RT |
| CAS Number | 141063-77-6 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Product Datasheets
Please contact Customer Service.
References
References are publications that support the products' biological activity.
Nilsson et al (1992) Amide, urea and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. J.Med.Chem. 35 2787 PMID: 1379640
View Related Products by Target
View Related Products by Product Action
Keywords: 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethylammonium iodide, supplier, Non-selective, Muscarinics, Non-selective, Muscarinics, Tocris Bioscience
Citations for 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide
Citations are publications that use Tocris products.
Currently there are no citations for 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide.
Reviews for 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide
There are currently no reviews for this product. Be the first to review 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide and earn rewards!
Have you used 4-[N-(4-Chlorophenyl)carbamoyloxy]-4-pent-2-ynyl-trimethyl ammonium iodide?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and Europe
Submit a ReviewLiterature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
GPCR Product Listing
A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:
- Rhodopsin-like Receptors
- Secretin-like Receptors
- Glutamate Receptors
- Frizzled Receptors
- GPCR Signaling
Alzheimer's Poster
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.
Cardiovascular Poster
Cardiovascular disease remains one of the major causes of morbidity and mortality in the Western world and therefore this therapeutic area continues to be of great interest to researchers. This poster highlights the key GPCRs regulating vascular reactivity.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Schizophrenia Poster
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.
